Xeris Biopharma Holdings, Inc.
← Back to XERS Overview

Xeris Biopharma Holdings, Inc. (XERS)

Solvency & Capital Structure

Total Debt

$37.3M

Net Debt

-$74.4M

Xeris Biopharma Holdings, Inc. currently has $37.3M in total debt. Net debt is -$74.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

XERSQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.040.11-0.07Net Cash0.399.5%
2025-12-310.040.11-0.07Net Cash0.389.8%
2025-09-300.040.09-0.05Net Cash0.3710.3%
2025-06-300.260.060.200.3376.9%
2025-03-310.270.060.210.3285.2%
2024-12-310.270.070.200.3284.0%
2024-09-300.270.070.200.3284.4%
2024-06-300.270.080.190.3381.3%
2024-03-310.270.090.180.3479.8%
2023-12-310.230.070.160.3271.0%
2023-09-300.230.070.160.3369.5%
2023-06-300.220.080.140.3368.4%
2023-03-310.200.100.100.3261.7%
2022-12-310.200.120.080.3457.5%
2022-09-300.140.090.050.3045.7%
2022-06-300.140.110.030.3243.3%
2022-03-310.140.130.010.3440.9%
2021-12-310.090.10-0.01Net Cash0.3028.9%
2021-09-300.090.09-0.01Net Cash0.1366.8%
2021-06-300.090.12-0.03Net Cash0.1557.7%
2021-03-310.090.14-0.05Net Cash0.1752.1%
2020-12-310.090.13-0.05Net Cash0.1654.7%
2020-09-300.120.14-0.02Net Cash0.1770.1%
2020-06-300.110.14-0.03Net Cash0.1766.0%
2020-03-310.060.10-0.04Net Cash0.1250.2%
2019-12-310.060.08-0.02Net Cash0.1153.5%
2019-09-300.060.10-0.04Net Cash0.1345.4%
2019-06-300.030.12-0.09Net Cash0.1324.2%
2019-03-310.030.15-0.12Net Cash0.1620.0%
2018-12-310.030.11-0.08Net Cash0.1226.6%
2018-09-300.030.13-0.10Net Cash0.1423.0%
2018-06-300.020.13-0.12Net Cash0.1413.1%
2018-03-310.020.06-0.04Net Cash0.0629.3%
2017-12-310.000.04-0.04Net Cash0.040.0%
2017-03-310.000.03-0.03Net Cash0.00